PLA2G1B and chronic obstructive pulmonary disease: These findings expand the current understanding of PLA2G1B mechanisms and its involvement in the pathophysiological processes of COPD, suggesting that targeted overexpression of PLA2G1B in epithelial cells may hold therapeutic potential in mitigating COPD progression.